Evidence map›Paper›PMID 35132322›Full record

ArticleCase reports in medicine2022

Giant Parathyroid Adenoma-Associated Fracture, Not All Lytic Bone Lesions are

Jose C Alvarez-Payares, Marcel E Ribero, Sara Ramírez-Urrea, María C Fragozo-Ramos, Jose E Agámez-Gómez, Alejandro Román-González, Luis F Arias, Roberto Benavides Arenas, Fernando López-Urbano

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Jose C Alvarez-PayaresInternal Medicine Department, Universidad de Antioquia, Hospital Universitario, San Vicente Fundación, Medellín, Colombia.ORCID https://orcid.org/0000-0002-0901-3866
Marcel E RiberoInternal Medicine Department, Universidad de Antioquia, Hospital Universitario, San Vicente Fundación, Medellín, Colombia.
Sara Ramírez-UrreaGeneral Medicine, Fundación Universitaria San Martín, Medellín, Colombia.ORCID https://orcid.org/0000-0001-8463-5641
María C Fragozo-RamosEndocrinology and Metabolism Section, School of Medicine, Universidad de Antioquia, Endocrinology Department, Hospital San Vicente Fundación, Medellín, Colombia.ORCID https://orcid.org/0000-0002-6657-9989
Jose E Agámez-GómezGeneral Medicine, Universidad de Antioquia, IPS UniversitariaClínicaLeón XIII, Medellín, Colombia.ORCID https://orcid.org/0000-0001-5237-343X
Alejandro Román-GonzálezInternal Medicine Department, Endocrinology and Metabolism Section, School of Medicine, Universidad de Antioquia, Endocrinology Department, Hospital San Vicente Fundación, Medellín, Colombia.ORCID https://orcid.org/0000-0001-5942-1035
Luis F AriasPathology Departament, Universidad de Antioquia, Hospital Universitario San Vicente Fundación, Medellín, Colombia.ORCID https://orcid.org/0000-0001-5301-9264
Roberto Benavides ArenasInternal Medicine Department, Universidad de Antioquia, Hospital Universitario, San Vicente Fundación, Medellín, Colombia.
Fernando López-UrbanoInternal Medicine Department, Universidad de Antioquia, Hospital Universitario, San Vicente Fundación, Medellín, Colombia.ORCID https://orcid.org/0000-0002-1947-2636
Hospital Universitario de San Vicente Fundación · COSaint Martin University · COUniversidad de Antioquia · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDue to the early diagnosis of primary hyperparathyroidism the musculoskeletal manifestations of this disease are becoming less frequent. When this disease manifests secondary to a giant adenoma, it presents with more aggressive symptoms and can have important repercussions such as the hungry bone syndrome after parathyroidectomy. There are few reported cases of hyperparathyroidism secondary to a giant adenoma in the literature, as the presence of a brown tumor is often misinterpreted as a metastatic lesion from an unknown primary tumor.

methodsWe describe a case and performed a literature review to identify all case reports. A literature search was carried out on PubMed/MEDLINE and EMBASE bibliographic databases. All available studies from May 2009 to May 2021 were included. Data were tabulated, and outcomes were cumulatively analyzed.

resultsTwenty-four cases of primary hyperparathyroidism due to giant adenoma have been described; the majority were women, with a mean age of 52 years. They presented with heterogeneous symptoms such as palpable nodules (45%), bone pain (33%), brown tumor (12.5%), asymptomatic (12.5%), metabolic profile with a mean calcemia of 13.8 mg/dL, PTH 1109 ng/L, and mean tumor weight of 47.24 g.

conclusionPrimary hyperparathyroidism due to giant adenoma increases the risk of developing potentially serious postoperative complications such as hungry bone syndrome. This implies the need of implementing preventive measures comprising administration of intravenous zoledronic acid and early supplementation of oral calcium to prevent complications after resection.

Identifiers

PMID35132322
PMCPMC8817849
OpenAlexW4212990683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.